FDA Issues Draft Guidance on Robotic Surgical Devices

The U.S. Food and Drug Administration (FDA) has released a preliminary guidance for manufacturers on premarket submissions for surgical medical devices that incorporate robotic technologies.

Issued in late September, the draft guidance, titled “Robotically-Assisted Surgical Devices-Premarket Submissions,” offers device manufacturers recommendations on non-clinical testing, clinical data, and labeling associated with certain robotically-assisted surgical devices (RASDs).

Specific devices included under the scope of the guidance include “teleoperated, software-controlled systems that integrate robotic technologies and subassemblies,” that are “designed to assist qualified practitioners in precisely positioning and controlling one or more surgical instruments…”

- Partner Content -

Choosing The Right Hipot Platform For Modern Manufacturing Electrical Safety

Modern manufacturing demands more than basic electrical safety testing. This article explains how to select the right hipot platform based on production volume, automation requirements, measurement precision, data traceability, and compliance needs. It compares the capabilities of Vitrek’s V7X, 95X, and V10X platforms for scalable, Industry 4.0-ready electrical safety testing environments.

A reminder that guidance documents issued by the FDA solely reflect the FDA’s current thinking and are intended to promote consistency in premarket submissions filed by device manufacturers.

Read the FDA’s draft guidance on premarket submissions for robotically-assisted surgical devices.

Comments can be submitted through November 24th (reference FDA Docket ID FDA-2026-N-9505-0001).

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -